Your search returned 2 results.

Results
	1.	Metformin synergistically enhances the antitumor activity of the third-generation EGFR-TKI CO-1686 in lung cancer cells through suppressing NF-κB signaling. [electronic resource] by Pan, Yong-Hong Lin, Cai-Yu Lu, Cong-Hua Li, Li Wang, Yu-Bo Chen, Heng-Yi He, Yong Producer: 20190816 In: The clinical respiratory journal vol. 12 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Combined treatment with metformin and gefitinib overcomes primary resistance to EGFR-TKIs with EGFR mutation via targeting IGF-1R signaling pathway. [electronic resource] by Pan, Yong-Hong Jiao, Lin Lin, Cai-Yu Lu, Cong-Hua Li, Li Chen, Heng-Yi Wang, Yu-Bo He, Yong Publication details: Biologics : targets & therapy 2018 In: Biologics : targets & therapy vol. 12 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

Refine your search